NASDAQ:URGN

UroGen Pharma News Headlines

$18.12
+0.77 (+4.44 %)
(As of 05/11/2021 02:57 PM ET)
Add
Compare
Today's Range
$17.45
$18.41
50-Day Range
$17.48
$20.94
52-Week Range
$17.01
$30.89
Volume2,484 shs
Average Volume184,011 shs
Market Capitalization$378.65 million
P/E RatioN/A
Dividend YieldN/A
Beta1.32

Headlines

UroGen Pharma (NASDAQ URGN) News Headlines Today

SourceHeadline
UroGen Pharma (URGN) Scheduled to Post Earnings on ThursdayUroGen Pharma (URGN) Scheduled to Post Earnings on Thursday
americanbankingnews.com - May 7 at 9:43 AM
UroGen Pharma (URGN) Set to Announce Quarterly Earnings on ThursdayUroGen Pharma (URGN) Set to Announce Quarterly Earnings on Thursday
americanbankingnews.com - May 7 at 9:42 AM
UroGen Pharma to Report First Quarter 2021 Financial Results on Thursday, May 13, 2021UroGen Pharma to Report First Quarter 2021 Financial Results on Thursday, May 13, 2021
finance.yahoo.com - May 6 at 12:17 PM
UroGen Pharma (NASDAQ:URGN) Price Target Cut to $50.00 by Analysts at HC WainwrightUroGen Pharma (NASDAQ:URGN) Price Target Cut to $50.00 by Analysts at HC Wainwright
americanbankingnews.com - May 3 at 11:32 AM
 Brokerages Expect UroGen Pharma Ltd. (NASDAQ:URGN) Will Announce Quarterly Sales of $8.41 Million Brokerages Expect UroGen Pharma Ltd. (NASDAQ:URGN) Will Announce Quarterly Sales of $8.41 Million
americanbankingnews.com - April 30 at 3:00 AM
UroGen Pharma Ltd. (NASDAQ:URGN) Expected to Post Earnings of -$1.27 Per ShareUroGen Pharma Ltd. (NASDAQ:URGN) Expected to Post Earnings of -$1.27 Per Share
americanbankingnews.com - April 28 at 10:34 AM
HC Wainwright Reaffirms Buy Rating for UroGen Pharma (NASDAQ:URGN)HC Wainwright Reaffirms Buy Rating for UroGen Pharma (NASDAQ:URGN)
americanbankingnews.com - April 27 at 8:37 AM
UroGen Pharma: Q4 Earnings InsightsUroGen Pharma: Q4 Earnings Insights
finance.yahoo.com - March 18 at 1:26 PM
UROGEN PHARMA (URGN) Reports Q4 Loss, Tops Revenue EstimatesUROGEN PHARMA (URGN) Reports Q4 Loss, Tops Revenue Estimates
finance.yahoo.com - March 18 at 1:26 PM
UroGen Pharma Announces $75 Million of Non-Dilutive Funding from RTW InvestmentsUroGen Pharma Announces $75 Million of Non-Dilutive Funding from RTW Investments
finance.yahoo.com - March 18 at 8:22 AM
UroGen Pharma Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Corporate DevelopmentsUroGen Pharma Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Corporate Developments
finance.yahoo.com - March 18 at 8:22 AM
Is UroGen Pharma Ltd.s (NASDAQ:URGN) Shareholder Ownership Skewed Towards Insiders?Is UroGen Pharma Ltd.'s (NASDAQ:URGN) Shareholder Ownership Skewed Towards Insiders?
finance.yahoo.com - March 12 at 5:03 PM
UroGen Pharma to Report Fourth Quarter and Full Year 2020 Financial Results on Thursday, March 18, 2021UroGen Pharma to Report Fourth Quarter and Full Year 2020 Financial Results on Thursday, March 18, 2021
finance.yahoo.com - March 11 at 9:54 AM
UroGen Pharma Announces March 2021 Conference ScheduleUroGen Pharma Announces March 2021 Conference Schedule
finance.yahoo.com - February 23 at 9:02 AM
UroGen Pharma Ltd. (NASDAQ:URGN): Are Analysts Optimistic?UroGen Pharma Ltd. (NASDAQ:URGN): Are Analysts Optimistic?
finance.yahoo.com - January 26 at 5:29 PM
Idaho Champion Drills Oxide Gold and Silver Near Historic Pits at Champagne Gold ProjectIdaho Champion Drills Oxide Gold and Silver Near Historic Pits at Champagne Gold Project
finance.yahoo.com - January 19 at 3:48 PM
UroGen Pharma and MD Anderson Announce Strategic Research Collaboration to Advance Investigational Treatment for High-Grade Bladder CancerUroGen Pharma and MD Anderson Announce Strategic Research Collaboration to Advance Investigational Treatment for High-Grade Bladder Cancer
finance.yahoo.com - January 13 at 12:19 PM
UroGen Pharma to Present at the Virtual 39th Annual J.P. Morgan Healthcare ConferenceUroGen Pharma to Present at the Virtual 39th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 6 at 1:01 PM
UroGen Pharmas(NASDAQ:URGN) Share Price Is Down 50% Over The Past Three Years.UroGen Pharma's(NASDAQ:URGN) Share Price Is Down 50% Over The Past Three Years.
finance.yahoo.com - December 18 at 2:39 PM
Idaho Champion Extends Target at the Baner Gold Project with High Gold in Rock ChipsIdaho Champion Extends Target at the Baner Gold Project with High Gold in Rock Chips
finance.yahoo.com - December 7 at 7:38 AM
Metals & Mining Live Virtual Investor Conference December 8th and 9thMetals & Mining Live Virtual Investor Conference December 8th and 9th
finance.yahoo.com - December 4 at 8:49 AM
UroGen Pharma Announces Podium Presentation of Final Jelmyto® Data From Pivotal OLYMPUS Trial at the Annual Meeting of the Society of Urologic OncologyUroGen Pharma Announces Podium Presentation of Final Jelmyto® Data From Pivotal OLYMPUS Trial at the Annual Meeting of the Society of Urologic Oncology
finance.yahoo.com - December 3 at 5:46 PM
Hedge Funds Aren’t Crazy About UroGen Pharma Ltd. (URGN) AnymoreHedge Funds Aren’t Crazy About UroGen Pharma Ltd. (URGN) Anymore
finance.yahoo.com - November 29 at 10:43 PM
Notable Thursday Option Activity: AAP, URGN, TWLONotable Thursday Option Activity: AAP, URGN, TWLO
nasdaq.com - November 19 at 5:03 PM
Complete and Durable Responses Observed in OPTIMA II Phase 2b Final Results for UGN-102 in Patients with Low-Grade Intermediate Risk Non-Muscle Invasive Bladder CancerComplete and Durable Responses Observed in OPTIMA II Phase 2b Final Results for UGN-102 in Patients with Low-Grade Intermediate Risk Non-Muscle Invasive Bladder Cancer
finance.yahoo.com - November 17 at 12:54 PM
UroGen Pharma Ltd. (NASDAQ:URGN) Just Released Its Third-Quarter Earnings: Heres What Analysts ThinkUroGen Pharma Ltd. (NASDAQ:URGN) Just Released Its Third-Quarter Earnings: Here's What Analysts Think
finance.yahoo.com - November 12 at 8:20 AM
Centers for Medicare & Medicaid Services (CMS) Issues Permanent J-Code for UroGen’s Jelmyto ® Effective January 1, 2021Centers for Medicare & Medicaid Services (CMS) Issues Permanent J-Code for UroGen’s Jelmyto ® Effective January 1, 2021
businesswire.com - November 11 at 1:20 PM
Centers for Medicare & Medicaid Services (CMS) Issues Permanent J-Code for UroGen’s Jelmyto® Effective January 1, 2021Centers for Medicare & Medicaid Services (CMS) Issues Permanent J-Code for UroGen’s Jelmyto® Effective January 1, 2021
finance.yahoo.com - November 11 at 8:20 AM
UroGen Pharma Announces November 2020 Conference ScheduleUroGen Pharma Announces November 2020 Conference Schedule
finance.yahoo.com - November 10 at 10:17 AM
UroGen Pharma EPS beats by $0.15, beats on revenueUroGen Pharma EPS beats by $0.15, beats on revenue
seekingalpha.com - November 9 at 1:01 PM
UroGen Pharma Reports Third Quarter 2020 Financial Results and Recent Corporate DevelopmentsUroGen Pharma Reports Third Quarter 2020 Financial Results and Recent Corporate Developments
finance.yahoo.com - November 9 at 1:01 PM
Recap: UroGen Pharma Q3 EarningsRecap: UroGen Pharma Q3 Earnings
finance.yahoo.com - November 9 at 1:01 PM
UroGen Pharma Ltd. to Host Earnings CallUroGen Pharma Ltd. to Host Earnings Call
finance.yahoo.com - November 9 at 8:00 AM
UroGen Pharma to Report Third Quarter 2020 Financial Results on Monday, November 9, 2020UroGen Pharma to Report Third Quarter 2020 Financial Results on Monday, November 9, 2020
finance.yahoo.com - November 2 at 8:58 AM
Idaho Champion Gold Mobilizes Second Core Rig to Champagne ProjectIdaho Champion Gold Mobilizes Second Core Rig to Champagne Project
finance.yahoo.com - October 27 at 9:01 AM
UroGen Pharma Announces September 2020 Conference ScheduleUroGen Pharma Announces September 2020 Conference Schedule
finance.yahoo.com - September 10 at 10:50 AM
UroGen Pharma trades high; expands executive leadership teamUroGen Pharma trades high; expands executive leadership team
seekingalpha.com - September 9 at 2:55 PM
UroGen Pharma Expands Executive Team to Accelerate Platform Innovation and Drive Commercial GrowthUroGen Pharma Expands Executive Team to Accelerate Platform Innovation and Drive Commercial Growth
finance.yahoo.com - September 9 at 9:54 AM
UroGen Pharma: Phase 2 APOLLO Clinical Trial Did Not Meet Primary EndpointUroGen Pharma: Phase 2 APOLLO Clinical Trial Did Not Meet Primary Endpoint
nasdaq.com - August 27 at 9:10 AM
UroGen Pharma Announces Update on the Phase 2 Trial of an RTGel™ Hydrogel Formulation in Combination with BOTOX® (onabotulinumtoxinA) Intravesical Instillation for Overactive Bladder and Urinary IncontinenceUroGen Pharma Announces Update on the Phase 2 Trial of an RTGel™ Hydrogel Formulation in Combination with BOTOX® (onabotulinumtoxinA) Intravesical Instillation for Overactive Bladder and Urinary Incontinence
finance.yahoo.com - August 27 at 9:10 AM
UroGen Pharma Ltd. (URGN) Q2 2020 Earnings Call TranscriptUroGen Pharma Ltd. (URGN) Q2 2020 Earnings Call Transcript
finance.yahoo.com - August 10 at 8:50 PM
UroGen Pharma EPS beats by $0.14, beats on revenueUroGen Pharma EPS beats by $0.14, beats on revenue
seekingalpha.com - August 10 at 10:49 AM
What You Need To Know About UroGen Pharma Ltd.s (NASDAQ:URGN) Investor CompositionWhat You Need To Know About UroGen Pharma Ltd.'s (NASDAQ:URGN) Investor Composition
finance.yahoo.com - August 10 at 10:49 AM
UroGen Pharma Reports Second Quarter 2020 Financial Results and Recent Corporate DevelopmentsUroGen Pharma Reports Second Quarter 2020 Financial Results and Recent Corporate Developments
finance.yahoo.com - August 10 at 10:49 AM
What You Need To Know About UroGen Pharma Ltd.'s (NASDAQ:URGN) Investor CompositionWhat You Need To Know About UroGen Pharma Ltd.'s (NASDAQ:URGN) Investor Composition
finance.yahoo.com - August 10 at 10:49 AM
UroGen Pharma to Report Second Quarter 2020 Financial Results on Monday, August 10, 2020UroGen Pharma to Report Second Quarter 2020 Financial Results on Monday, August 10, 2020
finance.yahoo.com - August 3 at 9:15 AM
Hedge Funds Are Selling UroGen Pharma Ltd. (URGN)Hedge Funds Are Selling UroGen Pharma Ltd. (URGN)
finance.yahoo.com - June 15 at 11:30 PM
UroGen Pharma (URGN) Presents At Jefferies Healthcare Conference - SlideshowUroGen Pharma (URGN) Presents At Jefferies Healthcare Conference - Slideshow
seekingalpha.com - June 3 at 6:53 PM
UroGen Pharma to Present at Jefferies Virtual Healthcare ConferenceUroGen Pharma to Present at Jefferies Virtual Healthcare Conference
finance.yahoo.com - June 1 at 8:50 AM
Urogens mitomycin shows positive effect in mid-stage bladder cancer studyUrogen's mitomycin shows positive effect in mid-stage bladder cancer study
seekingalpha.com - May 15 at 12:40 PM
This page was last updated on 5/11/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.